Feasibility and acceptability for LION, a fully remote, randomized clinical trial within the VA for light therapy to improve sleep in Veterans with and without TBI: An MTBI2 sponsored protocol
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0305305 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2025. Verfasst von Jonathan E Elliott und 15 weiteren Autor:innen. Beteiligte Einrichtung: VA Portland Health Care System, Portland, Oregon, United States of America. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Feasibility Studies, Phototherapy, Sleep. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: RRD VA, NCCIH NIH HHS, U.S. Department of Defense Military Traumatic Brain Injury Initiative.
Abstract (Originalsprache)
Sleep-wake disturbances frequently present in Veterans with mild traumatic brain injury (mTBI). These TBI-related sleep impairments confer significant burden and commonly exacerbate other functional impairments. Therapies to improve sleep following mTBI are limited and studies in Veterans are even more scarce. In our previous pilot work, morning bright light therapy (MBLT) was found to be a feasible behavioral sleep intervention in Veterans with a history of mTBI; however, this was single-arm, open-label, and non-randomized, and therefore was not intended to establish efficacy. The present study, LION (light vs ion therapy) extends this preliminary work as a fully powered, sham-controlled, participant-masked randomized controlled trial (NCT03968874), implemented as fully remote within the VA (target n = 120 complete). Randomization at 2:1 allocation ratio to: 1) active: MBLT (n = 80), and 2) sham: deactivated negative ion generator (n = 40); each with identical engagement parameters (60-min duration; within 2-hrs of waking; daily over 28-day duration). Participant masking via deception balanced expectancy assumptions across arms. Outcome measures were assessed following a 14-day baseline (pre-intervention), following 28-days of device engagement (post-intervention), and 28-days after the post-intervention assessment (follow-up). Primary outcomes were sleep measures, including continuous wrist-based actigraphy, self-report, and daily sleep dairy entries. Secondary/exploratory outcomes included cognition, mood, quality of life, circadian rhythm via dim light melatonin onset, and biofluid-based biomarkers. Participant drop out occurred in
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- VA Portland Health Care System, Portland, Oregon, United States of America.
- Department of Neurology, Oregon Health & Science University, Portland, Oregon, United States of America.
- Military Traumatic Brain Injury Initiative (MTBI2), Bethesda, Maryland, United States of America.
- VISN 20 Northwest Mental Illness Research, Education and Clinical Center (MIRECC), VA Puget Sound Health Care System, Seattle, Washington, United States of America.
- VA San Diego Health Care System, Research Service; Center of Excellence for Stress and Mental Health, San Diego, San Diego, California, United States of America.
- Department of Psychiatry, University of California San Diego, La Jolla, California, United States of America.
ORCID-Profile: Jonathan E Elliott, Miranda M Lim
Förderung
- RRD VA
- NCCIH NIH HHS
- U.S. Department of Defense Military Traumatic Brain Injury Initiative
- U.S. Department of Veterans Affairs Career Development Award
- National Institute of Health
- Congressionally Directed Medical Research Programs
- U.S. Department of Veterans Affairs RRD Research Career Scientist Award
Zitieren
APA
Elliott, J. E., Brewer, J. S., Keil, A. T., Ligman, B. R., Bryant-Ekstrand, M. D., McBride, A. A., Powers, K., Sicard, S. J., Twamley, E. W., O'Neil, M. E., Hildebrand, A. D., Nguyen, T., Morasco, B. J., Gill, J. M., Dengler, B. A., & Lim, M. M. (2025). Feasibility and acceptability for LION, a fully remote, randomized clinical trial within the VA for light therapy to improve sleep in Veterans with and without TBI: An MTBI2 sponsored protocol. PLOS ONE. https://doi.org/10.1371/journal.pone.0305305
Vancouver
Elliott JE, Brewer JS, Keil AT, Ligman BR, Bryant-Ekstrand MD, McBride AA, et al. Feasibility and acceptability for LION, a fully remote, randomized clinical trial within the VA for light therapy to improve sleep in Veterans with and without TBI: An MTBI2 sponsored protocol. PLOS ONE. 2025. doi:10.1371/journal.pone.0305305
BibTeX
@article{Elliott2025,
author = {Elliott, Jonathan E and Brewer, Jessica S and Keil, Allison T and Ligman, Brittany R and Bryant-Ekstrand, Mohini D and McBride, Alisha A and Powers, Katherine and Sicard, Savanah J and Twamley, Elizabeth W and O'Neil, Maya E and Hildebrand, Andrea D and Nguyen, Thuan and Morasco, Benjamin J and Gill, Jessica M and Dengler, Bradley A and Lim, Miranda M},
title = {Feasibility and acceptability for LION, a fully remote, randomized clinical trial within the VA for light therapy to improve sleep in Veterans with and without TBI: An MTBI2 sponsored protocol},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0305305}
}
EUVIMED